We are live on ! Find out more
LVAC

LAVA Medtech Acquisition Corp. Class A Common Stock
LVAC

Delisted

LVAC was delisted on the 10th of May, 2023.

Back to rankings

54 hedge funds and large institutions have $116M invested in LAVA Medtech Acquisition Corp. Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 8 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 8 | Existing positions closed: 7

12% more capital invested

Capital invested by funds: $104M → $116M (+$12.4M)

2% more funds holding

Funds holding: 53 → 54 (+1)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

Holders
54
Holders Change
+1
Holders Change %
+1.89%
% of All Funds
0.86%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
8
Increased
7
Reduced
12
Closed
7
Calls
$209K
Puts
–
Net Calls
+$209K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
QL
Quarry LP
New York
+$3.11M
2
UOC
UBS O'Connor
Illinois
+$2.94M
3
WCMNY
Westchester Capital Management (New York)
New York
+$2.38M
4
FTCM
First Trust Capital Management
Illinois
+$2.33M
5
PC
Periscope Capital
Ontario, Canada
+$2.08M

Top Sellers

Rank Fund Capital Flow
1
SC
Sculptor Capital
New York
-$4.39M
2
CCM
Context Capital Management
California
-$2.31M
3
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$776K
4
SAMU
SONA Asset Management (US)
New York
-$611K
5
WAM
Weiss Asset Management
Massachusetts
-$514K
Name Holding Trade Value Shares
Change 		Change in
Stake
PCM
26
Prelude Capital Management
New York
$1.37M +$1.36M +131,260 New
AMC
27
Atlas Merchant Capital
New York
$1.28M – – –
MF
28
Magnetar Financial
Illinois
$1.18M -$114K -10,969 -9%
SSA
29
Schonfeld Strategic Advisors
New York
$1.14M -$112K -10,780 -9%
DAM
30
Deltec Asset Management
New York
$1.06M +$1.05M +101,800 New
MTCM
31
Mint Tower Capital Management
Netherlands
$1.04M – – –
CC
32
Centiva Capital
New York
$848K +$842K +81,332 New
KL
33
KIM LLC
Kansas
$770K +$764K +73,799 New
Walleye Capital
34
Walleye Capital
New York
$686K – – –
Walleye Trading
35
Walleye Trading
New York
$563K – – –
RCM
36
Rivernorth Capital Management
Florida
$563K +$559K +54,009 New
EC
37
Elequin Capital
New York
$522K – – –
WA
38
Whitebox Advisors
Minnesota
$522K – – –
Bank of Montreal
39
Bank of Montreal
Ontario, Canada
$519K -$6.21K -600 -1%
BI
40
Bulldog Investors
New Jersey
$512K -$45.5K -4,400 -8%
HF
41
HRT Financial
New York
$507K -$3.1K -300 -0.6%
SV
42
Starboard Value
New York
$438K – – –
DFCM
43
Dark Forest Capital Management
Puerto Rico
$386K – – –
Verition Fund Management
44
Verition Fund Management
Connecticut
$366K – – –
Calamos Advisors
45
Calamos Advisors
Illinois
$261K – – –
LP
46
LMR Partners
United Kingdom
$261K – – –
GCL
47
Glazer Capital LLC
New York
$194K -$52K -5,021 -21%
VF
48
Virtu Financial
New York
$168K +$19.7K +1,907 +13%
DCM
49
Dupont Capital Management
Delaware
$104K – – –
ETH
50
Exos TFP Holdings
New York
$59.7K – – –
1
2
3

LVAC Hedge Fund Activity: Q1 2023 in Review

54 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) for Q1 2023, worth a combined $116M — up 12% from $104M a quarter earlier.

Buyers outnumbered sellers: 8 funds opened new LVAC positions and 7 closed out — a net gain of 1 holder — while 7 added to existing stakes and 12 trimmed.

The largest buyer was Quarry LP, opening a new position worth an estimated $3.11M. The largest seller was Sculptor Capital, exiting entirely with an estimated $4.39M sold.

  • 54 institutional investors held LAVA Medtech Acquisition Corp. Class A Common Stock (LVAC) as of Q1 2023, up from 53 in Q4 2022.
  • Funds reported $116M of LAVA Medtech Acquisition Corp. Class A Common Stock stock for Q1 2023, up 12% quarter-over-quarter.
  • 8 funds opened new LAVA Medtech Acquisition Corp. Class A Common Stock positions in Q1 2023 and 7 closed out, a net change of +1 holder.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock buyer in Q1 2023 was Quarry LP, an estimated $3.11M added.
  • The largest LAVA Medtech Acquisition Corp. Class A Common Stock seller in Q1 2023 was Sculptor Capital, an estimated $4.39M sold.

Based on aggregated 13F filings for Q1 2023.